Profile for Fate Therapeutics Inc. (FATE)

$ 13.63   -1.05 (-7.15%) Volume: 584.46k 4:00 PM EDT 18-Oct-2019
After Hours:  $ 13.50   -0.13 (-0.95%) Volume: 10.41k 7:59 PM EDT 18-Oct-2019
Business Description:
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.
Address: 3535 General Atomics Court, Suite 200, San Diego, CA, USA, 92121
Telephone: +1 858 875-1800 Website:
Facsimile: N/A Email: [email protected]
CEO: J. Scott Wolchko
Employees: 104 Market Cap: 891.21m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion
Indices: Biotechnology, Morningstar US Market Factor Tilt PR USD, Morningstar US Market Factor Tilt TR USD
Industry Classifications
Sector: Healthcare CIK: 1434316
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Biological Products, Except Diagnostic Substances (2836)